The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
There are obviously caveats and there is a lot more work to be done but the 2 words I take from the CEO's comments which give me a huge amount of comfort and hope are 'substantially' and 'transformational'. They say it all for me.
As ever market makers see a loss and mark the price down. These accounts are 6 months and more old. It's what's happened since and going forward that is important. Our CEO has, quite rightly, focused on the positives both in that year and going forward. Continued patience required.
If you look back through the RNS report schedule, even going back into last year, the company has pretty much issued one every 2-3 weeks (other than April this year when there were none) so my totally uneducated guess based on the law of averages is that there could be one anytime.